Falsified versions of GLP-1 receptor agonists reported

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-023-46014-3
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [1] Physician-Reported Use of GLP-1 Receptor Agonists in the UK
    Curtis, Sarah
    Jordan, Jessica B.
    Boye, Kristina S.
    Matza, Louis S.
    Adetunji, Omolara
    Martin, Sherry A.
    [J]. DIABETES, 2015, 64 : A298 - A298
  • [2] GLP-1 receptor agonists in NAFLD
    Petit, J. -M.
    Verges, B.
    [J]. DIABETES & METABOLISM, 2017, 43 : 2S28 - 2S33
  • [3] Emerging GLP-1 receptor agonists
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 607 - 618
  • [4] GLP-1 receptor agonists today
    Marre, Michel
    Penfornis, Alfred
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (03) : 317 - 327
  • [5] The Future of the GLP-1 Receptor Agonists
    Hirsch, Irl B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (15): : 1457 - 1458
  • [6] Positioning on GLP-1 receptor agonists
    Gimenez, Sergio
    Piskorz, Daniel
    Martinez Demaria, Diego
    Nanfara, Silvia
    Lorenzatti, Alberto
    Zapata, Gerardo
    Aguinaga Arrascue, Luis
    Perna, Eduardo
    [J]. REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2021, 50 : 4 - 10
  • [7] Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
    Seghieri, Marta
    Christensen, Alexander S.
    Andersen, Andreas
    Solini, Anna
    Knop, Filip K.
    Vilsboll, Tina
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [8] The Cardiovascular Effects of GLP-1 Receptor Agonists
    Okerson, Theodore
    Chilton, Robert J.
    [J]. CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e146 - e155
  • [9] GLP-1 receptor agonists in heart failure
    Vaduganathan, Muthiah
    [J]. LANCET, 2024, 404 (10454): : 727 - 729
  • [10] Novel GLP-1 receptor agonists for diabetes
    Garber, Alan J.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (01) : 45 - 57